stockrowMedtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Net margin
Medtronic PLC's net margin over the twelve months to 31 July 2026 was 13.9%, up 0.7 percentage points from fiscal 2026 (13.2%). Over the past ten years it has ranged from 10.4% (fiscal 2018) to 16.6% (fiscal 2020); the current reading is higher than 58% of that period. That is above the Medical Devices industry median of −14.5% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2026 | 13.2% | (0.70) |
| FY2025 | 13.9% | 2.54 |
| FY2024 | 11.4% | (0.67) |
| FY2023 | 12.0% | (3.87) |
| FY2022 | 15.9% | 3.93 |
| FY2021 | 12.0% | (4.59) |
| FY2020 | 16.6% | 1.40 |
| FY2019 | 15.2% | 4.80 |
| FY2018 | 10.4% | (3.20) |
| FY2017 | 13.6% | 1.29 |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jul 2026 | 15.1% | 2.39 |
| Apr 2026 | 12.7% | 0.00 |
| Jan 2026 | 12.7% | (2.65) |
| Oct 2025 | 15.3% | 3.21 |
| 43 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| DXCM DexCom, Inc. compare | 19.4% |
| BSX Boston Scientific Corporation compare | 16.6% |
| EW Edwards Lifesciences Corporation compare | 15.3% |
| MDT Medtronic PLC | 13.9% |
| SYK Stryker Corporation compare | 13.8% |
| STE STERIS plc compare | 13.4% |
| GEHC GE HealthCare Technologies Inc. compare | 9.95% |
| ABT Abbott Laboratories compare | 9.75% |
| PHG Koninklijke Philips N.V. compare | 5.34% |
| Medical Devices industry median | −14.5% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement